Synergy Pharmaceuticals Announces Full Exercise of Over

Synergy Pharmaceuticals, Inc. (Nasdaq: SGYPD) announced the full exercise of the over-allotment option granted to the underwriters to purchase 281250 additional units, at a public offering price of $8.00 per unit, in connection with its
Benzinga – Stock Market Quotes,…